SMOX, spermine oxidase, 54498

N. diseases: 91; N. variants: 12
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0014544
Disease: Epilepsy
Epilepsy
0.010 AlteredExpression disease BEFREE In this study, we analysed the effect of spermine oxidase over-expression in a different epileptic model, pentylenetetrazole. 31197571 2020
CUI: C4317109
Disease: Epileptic Seizures
Epileptic Seizures
0.010 Biomarker phenotype BEFREE The transgenic mouse line Dach-SMOX, with CD1 background, specifically overexpressing spermine oxidase in brain cortex, has been proven to be highly susceptible to epileptic seizures and excitotoxic stress induced by kainic acid. 31197571 2020
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.010 Biomarker disease BEFREE Furthermore, we investigated trans-PAO's impact on hyperlipidemia-induced inflammation and atherosclerosis progression in these mice. 31422082 2019
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.010 Biomarker disease BEFREE Furthermore, we investigated trans-PAO's impact on hyperlipidemia-induced inflammation and atherosclerosis progression in these mice. 31422082 2019
CUI: C0011847
Disease: Diabetes
Diabetes
0.010 AlteredExpression disease BEFREE A significant, inverse correlation between circulating trans-PAO levels and diabetes incidence and cardiovascular mortality has been reported. 31422082 2019
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.010 AlteredExpression group BEFREE A significant, inverse correlation between circulating trans-PAO levels and diabetes incidence and cardiovascular mortality has been reported. 31422082 2019
CUI: C0011884
Disease: Diabetic Retinopathy
Diabetic Retinopathy
0.010 Biomarker disease BEFREE Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy. 31207342 2019
CUI: C0020473
Disease: Hyperlipidemia
Hyperlipidemia
0.010 Biomarker disease BEFREE Furthermore, we investigated trans-PAO's impact on hyperlipidemia-induced inflammation and atherosclerosis progression in these mice. 31422082 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.010 Biomarker disease BEFREE In addition, LYZOX was shown to inhibit the growth of P. aeruginosa (NBRC 13275 and PAO1), A. baumannii and MRSA better than its components. 31136634 2019
CUI: C0003872
Disease: Arthritis, Psoriatic
Arthritis, Psoriatic
0.010 Biomarker disease BEFREE In lung tissue, increased infiltration of inflammatory cells, elevated lung injury and augmented cellular senescence was shown in mice with CLP followed by sublethal PA infection, and these observations reached a higher rank when higher (H) loads PA (PAO1) were administered to CLP mice (CLP + PAO1-H). 30649401 2018
CUI: C0004096
Disease: Asthma
Asthma
0.010 Biomarker disease BEFREE We found loss of the polyamine catabolic enzymes spermidine/spermine-N (1)-acetyltransferase-1 (SAT1) and spermine oxidase (SMOX) predominantly in bronchial epithelial cells (BECs) of human asthmatic lung samples and mice with AAI. 29729200 2018
CUI: C0009319
Disease: Colitis
Colitis
0.010 Biomarker disease BEFREE Herein, we utilized <i>Smox</i>-deficient mice to examine the role of SMOX in two murine colitis models, <i>Citrobacter rodentium</i> infection and dextran sulfate sodium (DSS)-induced epithelial injury.In <i>C. rodentium</i>-infected wild-type (WT) mice, there were marked increases in colon weight/length and histologic injury, with mucosal hyperplasia and inflammatory cell infiltration; these changes were ameliorated in <i>Smox<sup>-/-</sup></i> mice. 29922289 2018
CUI: C0014038
Disease: Encephalitis
Encephalitis
0.010 AlteredExpression disease BEFREE The objective was to analyze neurotrophic and oxidative parameters that could be related to midbrain dopamine neuronal loss or brain inflammation in the CSF of elderly subjects: 1) levels of the dopaminotrophic factors BDNF, GDNF, persephin, and neurturin, 2) levels of the proinflammatory factors TGFβ<sub>1</sub> and TGFβ<sub>2</sub>; 3) activity of main antioxidant enzymes (catalases, glutathione-peroxidase, glutathione-reductase, glutathione-S-transferases, peroxirredoxins, and superoxide-dismutases), 4) ferritin content, antioxidant protein which reduces reactive free iron, and 5) antioxidant potential of the cerebrospinal fluid.ELISA and PAO tests were used. 29775745 2018
CUI: C0021390
Disease: Inflammatory Bowel Diseases
Inflammatory Bowel Diseases
0.010 AlteredExpression group BEFREE In addition, we reported that SMOX can be upregulated in humans with inflammatory bowel disease. 29922289 2018
CUI: C0026106
Disease: Mild Mental Retardation
Mild Mental Retardation
0.010 AlteredExpression disease BEFREE Using a library of phages that infect two different clinical isolates of <i>P. aeruginosa</i>, PAO1 and PA14, we compared the phenotypes imparted by the expression of individual phage morons. 30150232 2018
CUI: C0035243
Disease: Respiratory Tract Infections
Respiratory Tract Infections
0.010 Biomarker group BEFREE This study aimed to evaluate the time course of bacterial killing and resistance of meropenem and ciprofloxacin in combination against hypermutable and nonhypermutable <i>P. aeruginosa</i> Static concentration time-kill experiments over 72 h assessed meropenem and ciprofloxacin in mono- and combination therapies against PAO1 (nonhypermutable), PAOΔ<i>mutS</i> (hypermutable), and hypermutable isolates CW8, CW35, and CW44 obtained from CF patients with chronic respiratory infections. 30104278 2018
CUI: C0037199
Disease: Sinusitis
Sinusitis
0.010 Biomarker disease BEFREE Insertion of the stent in PAO-1-infected rabbits for 2 weeks resulted in significant improvement in sinusitis according to endoscopy scoring (p < 0.0001) and CT scoring (p < 0.002). 29334430 2018
CUI: C0158996
Disease: Anemia of prematurity
Anemia of prematurity
0.010 AlteredExpression disease BEFREE The effects of AOP treatments on bacterial gene expression was examined using Pseudomonas aeruginosa strain PAO1 as a model-organism bacterium. 29448190 2018
CUI: C0276289
Disease: Zika Virus Infection
Zika Virus Infection
0.010 AlteredExpression disease BEFREE This antiviral effect was mediated by the upregulation of two polyamine catabolic enzymes, spermine oxidase, and spermidine (SMOX)/spermine N1-acetyltransferase (SAT1) as apparent reduction of the ZIKV infection following heterologous expression of SMOX and SAT1. 30040423 2018
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.010 Biomarker disease BEFREE In the present study, we evaluate the volatile metabolites produced by P. aeruginosa (PAO1)-infected, RSV-infected, co-infected, or uninfected CF bronchial epithelial (CFBE) cells, in vitro. 29735804 2018
CUI: C0877009
Disease: Muscle fibrosis
Muscle fibrosis
0.010 AlteredExpression phenotype BEFREE Normalization of either Amd1 or Smox expression in dy2j/dy2j TA ameliorates muscle fibrosis, reduces overactive profibrotic TGF-β pathway and leads to improved locomotion. 29566247 2018
CUI: C1853926
Disease: NONAKA MYOPATHY
NONAKA MYOPATHY
0.010 Biomarker disease BEFREE P. aeruginosa katA<sup>-</sup> mutant was more sensitive than wild-type strain PAO1 to wide-spectrum light and blue LED (464 nm) treatments. 29709605 2018
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.010 Biomarker disease BEFREE Knockdown of SMOX inhibited HCC cell proliferation, arrested cell cycle at S phase, and resulted in an increase of apoptosis. 29923661 2018
CUI: C0002395
Disease: Alzheimer's Disease
Alzheimer's Disease
0.010 Biomarker disease BEFREE 6-Hydroxy-l-nicotine (6HLN), a nicotine derivative from nicotine degradation by Arthrobacter nicotinovorans pAO1 strain was found to improve behavioral deficits and to reverse oxidative stress in the rat hippocampus.Rats were given CHL (10mg/kg, i.p.) were used as an Alzheimer's disease-like model. 27951416 2017
CUI: C0003873
Disease: Rheumatoid Arthritis
Rheumatoid Arthritis
0.010 Biomarker disease BEFREE However, treatment with KAAD-cyclopamine or transfection with Smo-siRNA suppressed migration of RA-FLSs and showed an inhibitory effect of Rho GTPase signaling. 28261216 2017